Position
Squarepoint Ops LLC in Coherus Oncology, Inc.
Back to the book · All holders of CHRS
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $25K$1.42 → $1.69
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 92.8K | $131.7K | — | — | — | 0.0% |
| Q1 2026 | 194.4K | $328.5K | $1.69 | $25K | $171.8K | 0.0% |